據報阿里巴巴-SW(09988.HK)通義千問已完成備案工作 待正式上線
《新浪科技》報道,根據國家七部委聯合公佈的《生成式人工智能服務管理暫行辦法》指導要求,阿里巴巴-SW(09988.HK)旗下通義千問已完成備案工作,待正式上線,首批通過備案的名單預計將在一周內陸續由各地方相關管理部門通過。
今早(31日)有傳百度-SW(09888.HK)、字節、商湯-W(00020.HK)、中科院旗下紫東太初、百川智能、智譜華章等8個企業或機構的大模型通過備案的名單,可正式上線面向公眾提供服務,但通義千問、360智腦及訊飛星火等均不在首批獲批名單中。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.